Literature DB >> 16682562

Position-specific chemical modification of siRNAs reduces "off-target" transcript silencing.

Aimee L Jackson1, Julja Burchard, Devin Leake, Angela Reynolds, Janell Schelter, Jie Guo, Jason M Johnson, Lee Lim, Jon Karpilow, Kim Nichols, William Marshall, Anastasia Khvorova, Peter S Linsley.   

Abstract

Transfected siRNAs regulate numerous transcripts sharing limited complementarity to the RNA duplex. This unintended ("off-target") silencing can hinder the use of RNAi to define gene function. Here we describe position-specific, sequence-independent chemical modifications that reduced silencing of partially complementary transcripts by all siRNAs tested. Silencing of perfectly matched targets was unaffected by these modifications. The chemical modification also reduced off-target phenotypes in growth inhibition studies. Key to the modification was 2'-O-methyl ribosyl substitution at position 2 in the guide strand, which reduced silencing of most off-target transcripts with complementarity to the seed region of the siRNA guide strand. The sharp position dependence of 2'-O-methyl ribosyl modification contrasts with the broader position dependence of base-pair substitutions within the seed region, suggesting a role for position 2 of the guide strand distinct from its effects on pairing to target transcripts.

Mesh:

Substances:

Year:  2006        PMID: 16682562      PMCID: PMC1484422          DOI: 10.1261/rna.30706

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  32 in total

1.  Small interfering RNAs containing full 2'-O-methylribonucleotide-modified sense strands display Argonaute2/eIF2C2-dependent activity.

Authors:  Bryan A Kraynack; Brenda F Baker
Journal:  RNA       Date:  2005-11-21       Impact factor: 4.942

2.  Target accessibility dictates the potency of human RISC.

Authors:  Kirk M Brown; Chia-Ying Chu; Tariq M Rana
Journal:  Nat Struct Mol Biol       Date:  2005-04-24       Impact factor: 15.369

3.  Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation.

Authors:  Shveta Bagga; John Bracht; Shaun Hunter; Katlin Massirer; Janette Holtz; Rachel Eachus; Amy E Pasquinelli
Journal:  Cell       Date:  2005-08-26       Impact factor: 41.582

4.  Widespread siRNA "off-target" transcript silencing mediated by seed region sequence complementarity.

Authors:  Aimee L Jackson; Julja Burchard; Janell Schelter; B Nelson Chau; Michele Cleary; Lee Lim; Peter S Linsley
Journal:  RNA       Date:  2006-05-08       Impact factor: 4.942

5.  Off-target effects by siRNA can induce toxic phenotype.

Authors:  Yuriy Fedorov; Emily M Anderson; Amanda Birmingham; Angela Reynolds; Jon Karpilow; Kathryn Robinson; Devin Leake; William S Marshall; Anastasia Khvorova
Journal:  RNA       Date:  2006-05-08       Impact factor: 4.942

6.  Structural insights into mRNA recognition from a PIWI domain-siRNA guide complex.

Authors:  James S Parker; S Mark Roe; David Barford
Journal:  Nature       Date:  2005-03-31       Impact factor: 49.962

7.  Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs.

Authors:  Lee P Lim; Nelson C Lau; Philip Garrett-Engele; Andrew Grimson; Janell M Schelter; John Castle; David P Bartel; Peter S Linsley; Jason M Johnson
Journal:  Nature       Date:  2005-01-30       Impact factor: 49.962

8.  Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer.

Authors:  T R Hughes; M Mao; A R Jones; J Burchard; M J Marton; K W Shannon; S M Lefkowitz; M Ziman; J M Schelter; M R Meyer; S Kobayashi; C Davis; H Dai; Y D He; S B Stephaniants; G Cavet; W L Walker; A West; E Coffey; D D Shoemaker; R Stoughton; A P Blanchard; S H Friend; P S Linsley
Journal:  Nat Biotechnol       Date:  2001-04       Impact factor: 54.908

9.  The 1.19 A X-ray structure of 2'-O-Me(CGCGCG)(2) duplex shows dehydrated RNA with 2-methyl-2,4-pentanediol in the minor groove.

Authors:  D A Adamiak; W R Rypniewski; J Milecki; R W Adamiak
Journal:  Nucleic Acids Res       Date:  2001-10-15       Impact factor: 16.971

10.  siRNA-mediated off-target gene silencing triggered by a 7 nt complementation.

Authors:  Xiaoyu Lin; Xiaoan Ruan; Mark G Anderson; Jeffrey A McDowell; Paul E Kroeger; Stephen W Fesik; Yu Shen
Journal:  Nucleic Acids Res       Date:  2005-08-09       Impact factor: 16.971

View more
  270 in total

Review 1.  Action and reaction: the biological response to siRNA and its delivery vehicles.

Authors:  Rosemary L Kanasty; Kathryn A Whitehead; Arturo J Vegas; Daniel G Anderson
Journal:  Mol Ther       Date:  2012-01-17       Impact factor: 11.454

Review 2.  RNA interference trigger variants: getting the most out of RNA for RNA interference-based therapeutics.

Authors:  Nicholas M Snead; John J Rossi
Journal:  Nucleic Acid Ther       Date:  2012-06       Impact factor: 5.486

3.  Distinct regulation of cytoplasmic calcium signals and cell death pathways by different plasma membrane calcium ATPase isoforms in MDA-MB-231 breast cancer cells.

Authors:  Merril C Curry; Nicole A Luk; Paraic A Kenny; Sarah J Roberts-Thomson; Gregory R Monteith
Journal:  J Biol Chem       Date:  2012-06-25       Impact factor: 5.157

4.  Dual-targeting siRNAs.

Authors:  Katrin Tiemann; Britta Höhn; Ali Ehsani; Stephen J Forman; John J Rossi; Pål Saetrom
Journal:  RNA       Date:  2010-04-21       Impact factor: 4.942

5.  Signatures of RNA binding proteins globally coupled to effective microRNA target sites.

Authors:  Anders Jacobsen; Jiayu Wen; Debora S Marks; Anders Krogh
Journal:  Genome Res       Date:  2010-05-27       Impact factor: 9.043

6.  Reduced seed region-based off-target activity with lentivirus-mediated RNAi.

Authors:  Richard A Klinghoffer; Jill Magnus; Janell Schelter; Michele Mehaffey; Casey Coleman; Michele A Cleary
Journal:  RNA       Date:  2010-03-26       Impact factor: 4.942

Review 7.  Systems biology in immunology: a computational modeling perspective.

Authors:  Ronald N Germain; Martin Meier-Schellersheim; Aleksandra Nita-Lazar; Iain D C Fraser
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

8.  Rational design of therapeutic siRNAs: minimizing off-targeting potential to improve the safety of RNAi therapy for Huntington's disease.

Authors:  Ryan L Boudreau; Ryan M Spengler; Beverly L Davidson
Journal:  Mol Ther       Date:  2011-09-27       Impact factor: 11.454

9.  Delivery of small interfering RNA by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayers.

Authors:  Carlee E Ashley; Eric C Carnes; Katharine E Epler; David P Padilla; Genevieve K Phillips; Robert E Castillo; Dan C Wilkinson; Brian S Wilkinson; Cameron A Burgard; Robin M Kalinich; Jason L Townson; Bryce Chackerian; Cheryl L Willman; David S Peabody; Walker Wharton; C Jeffrey Brinker
Journal:  ACS Nano       Date:  2012-02-14       Impact factor: 15.881

Review 10.  Short non-coding RNA biology and neurodegenerative disorders: novel disease targets and therapeutics.

Authors:  Marc S Weinberg; Matthew J A Wood
Journal:  Hum Mol Genet       Date:  2009-04-15       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.